Immunoassay Analyzer Leasing for Labs
Access automated immunoassay platforms at lower upfront costs—equipment sourced to order
What Is an Immunoassay Analyzer?
Immunoassay analyzers detect and quantify biological markers such as hormones, proteins, and infectious agents using antigen-antibody reactions. They are essential in clinical diagnostics for applications like endocrine testing, tumor markers, cardiac markers, and infectious disease screening. These systems provide sensitive, high-throughput testing critical for accurate diagnosis and patient monitoring.
Why Lease an Immunoassay Analyzer?
From routine hormone panels to STAT infectious disease testing, immunoassay analyzers are vital to timely, accurate diagnostics. But acquiring these platforms—especially those with chemiluminescence, ELISA automation, or integrated sample prep—can require a significant capital investment.
Leasing offers a more flexible, budget-friendly approach. It enables clinical labs, hospitals, and diagnostics providers to adopt or upgrade advanced testing capabilities without delaying timelines or straining capital. As testing menus grow and patient volumes increase, leasing ensures your instrumentation can keep pace.
Where Leasing an Immunoassay Analyzer Adds Value
Immunoassay analyzers are vital for detecting hormones, biomarkers, infectious agents, and more in clinical diagnostics and research. But systems with high throughput, automation, and LIS integration often come with steep upfront costs.
Leasing can be a smart choice when:
- You need lease terms that align with clinical volume or regulatory timelines—Structure payments to match testing demand and compliance goals.
- You want full support from sourcing to validation—Get turnkey setup with equipment delivery, installation, and operational qualification.
- You’re looking to unlock capital from existing systems—Use sale-leaseback options to preserve cash while keeping instruments in service.
Whether you're expanding your test menu or optimizing lab operations, leasing an immunoassay analyzer helps you stay agile, compliant, and financially efficient.
Why Teams Lease with Excedr
Founder-friendly, non-dilutive capital
Ideal for early-stage or venture-backed teams—and a smart option for any lab looking to preserve equity while scaling.
Flexibility on equipment choice
No inventory limitations. You choose the system that fits your workflow—we handle the financing.
Lease terms aligned with your growth
2–5 year terms that support your budget, equipment lifecycle, and scaling timeline.
Quick approvals, flexible terms
Get approved in days—not weeks—with no collateral, IP pledges, or debt covenants required.
White-glove service & procurement
Equipment sourcing, vendor coordination, and lease logistics are streamlined to reduce your team’s internal workload.
Reliable support when it matters
Our vendor relationships help resolve issues quickly—so you stay productive and hit key milestones.
Leasing Solutions We Provide
Operating Leases
Treat lease payments as operating expenses, not debt. This simplifies accounting and preserves flexibility.
Sale Lease-Backs
Convert owned equipment into working capital. Keep it off your balance sheet and treat payments as operating expenses.
Popular Immunoassay Analyzer Manufacturers
Straightforward Application Process
Tell Us What You Need
Already have a quote or PO? Just let us know the equipment you want to lease—we’ll take it from there.
Get Approved Quickly
Our in-house underwriting team reviews your financials fast—no outsourcing, no red tape—so you get a decision in days, not weeks.
We Handle the Rest
We handle the logistics and coordinate with the vendor so you can get to work—no upfront capital required.
Helping Scientists Scale & Succeed
"We used Excedr when it was time for us to make a large capital equipment purchase and the whole leasing process was smooth, quick, and seamless.
As a busy start-up CEO, I am always aware of how important it is to keep our science progressing while on a tight budget.
Working with Excedr made it possible for us to accelerate our scientific discovery pipeline without a large outlay of capital."
Jessica Grossman
CEO, IgGenix
"Building a biotech is a lot of work. Excedr has been a dynamite partner in making that scaling happen.
They were a great partner when scaling Distributed Bio from an 8 member lab team to 35 members by the time of acquisition. When I started Centivax, Jon was one of the first people I called.
I recommend them for any biotech startup."
Jacob Glanville
CEO & President, Centivax
"Securing top-tier lab equipment while managing cash flow is a constant challenge. Excedr has been an invaluable partner in helping KiraGen Bio access the high-quality instrumentation we need without the heavy upfront costs.
Their flexible leasing options and outstanding support allow us to focus on advancing our research rather than worrying about equipment procurement and maintenance. For any biotech startup looking to scale efficiently, I can’t recommend Excedr enough."
Aaron Edwards
Co-Founder & CEO, KiraGen Bio
"Excedr helped us to finance a BLI system about a year ago. Sylvia did an excellent job at helping us to understand our options, since our company was new to equipment financing.
The leasing process was fast and easy when compared with self-funding our purchase, plus the speed and ease with which Excedr onboarded us freed up our team’s time to focus on research and grant management.
Max Brennan
General Counsel & VP Operations, Zab Bio
“The lease of our Zeiss EVO10 electron microscope has significantly impacted our outside analysis costs, realizing a significant savings in the 1st year.
Having the instrument on-site has greatly improved our response times to field issues and fabrication challenges, while improving our Engineering and Production Teams' overall understanding of our product lines."
Tom Raber
Principal Mechanical Technician, Plug Power
Frequently Asked Questions
Lease Immunoassay Analyzers & Accelerate Diagnostic Testing
Don’t let capital limitations delay your testing expansion. Our leasing program is designed to remove friction from equipment procurement so you can stay focused on accuracy, throughput, and patient care.